A novel in vitro model of tumor angiogenesis

[1]  N. Sheibani,et al.  Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  O. Volpert,et al.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity , 1993, The Journal of cell biology.

[3]  W. Stewart,et al.  An in vitro three-dimensional coculture model of cerebral microvascular angiogenesis and differentiation , 1997, In Vitro Cellular & Developmental Biology - Animal.

[4]  W. Frazier,et al.  Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta. , 1994, Journal of cell science.

[5]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[6]  O. Volpert,et al.  The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression , 2004, Breast Cancer Research and Treatment.

[7]  J. Connolly,et al.  Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Iruela-Arispe,et al.  Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[9]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Steeg,et al.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. , 1994, Cancer research.

[11]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[12]  G. Goldstein,et al.  Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors , 1993, Brain Research.